首页 | 官方网站   微博 | 高级检索  
     

核苷类似物联合人工肝治疗慢性重型肝炎疗效观察
引用本文:李谦,唐克诚,袁桂玉,杨积明,李海,韩贵兰,刘国旺.核苷类似物联合人工肝治疗慢性重型肝炎疗效观察[J].临床肝胆病杂志,2007,23(4):255-257.
作者姓名:李谦  唐克诚  袁桂玉  杨积明  李海  韩贵兰  刘国旺
作者单位:天津市传染病医院,天津,300192
摘    要:研究核苷类似物联合人工肝治疗慢性乙型重型肝炎疗效。将58例慢性乙型重型肝炎患者分为三组,核苷类似物联合人工肝治疗组、单用人工肝治疗组、单用核苷类似物治疗组,观察治疗效果。联合治疗组病死率22.22%,胆红素下降明显,白蛋白回升,凝血酶原活动度好转,HBV DNA转阴或载量下降。血浆置换治疗可降低血清HBV DNA水平。核苷类似物联合人工肝治疗可加快肝功能好转,缩短病程,降低病死率,降低血清HBV DNA水平。

关 键 词:人工肝  核苷类似物  HBVDNA  治疗
文章编号:1001-5256(2007)04-0255-03
修稿时间:2006-08-22

The efficacy of nucleosides plus artificial liver support system on treating chronic severe hepatitis
LI Qian, TANG Ke -cheng, YUAN Gui -yu,et al..The efficacy of nucleosides plus artificial liver support system on treating chronic severe hepatitis[J].Chinese Journal of Clinical Hepatology,2007,23(4):255-257.
Authors:LI Qian  TANG Ke -cheng  YUAN Gui -yu  
Affiliation:Tianjin Infectious Diseases Hospital, Tianfin 300192, China
Abstract:To study the efficacy of nucleosides plus artificial liver support system(ALSS) on treating chronic severe hepatitis.58 patients with chronic severe hepatitis B were divided into three groups: combined treating group with nucleosides plus ALSS,ALSS treating group and nucleosides treating group.The therapeutic efficacy was observed.In combined treating group,mortality was 25%,and liver function indexes,such as bilirubin,albumin,prothrombin time activity(PTA),and HBV DNA level,improved.Treating with nucleosides plus ALSS could accelerate the amelioration of liver function,shorten course of disease,decrease mortality and HBV DNA level.
Keywords:artificial liver support system(ALSS)  nucleosides  HBV DNA  therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号